A new survey by the Association of the British Pharmaceutical Industry (ABPI) into links between industry and academia shows a significant rise in the number of higher level apprenticeships across the pharmaceutical industry over the past four years.
Dr Sheuli Porkess of the ABPI applauds the Sector Deal 2 for helping to boost opportunities for patients to engage in research, but says there’s more to do.
The NHS Confederation and the ABPI have today published a new report to help the NHS and life sciences industry work more closely together.
King’s College London, Wellcome and pharmaceutical company MSD announced a collaboration and licencing deal today that could lead to a new class of pain medications.
Professor Carole Longson, Chief Scientific Officer at the Association of the British Pharmaceutical Industry gives her nominations for a woman in science to go on the £50 note.
In response to concerns about the impact a US trade deal would have on medicine pricing, the ABPI continues to emphasise that in the UK, we have very strict rules which control medicine spend.
New figures published today by the ABPI show that the pharmaceutical industry continues to invest significantly in UK research and development, working with healthcare professionals and organisations to improve care for NHS patients.
The ABPI has launched new guidance to make sure that joint working between the NHS and industry delivers ‘a triple win’ in benefits for patients, the NHS and companies.
The ABPI has appointed Dr Richard Torbett as its new Chief Executive. He'll take up the job from 1 January.